A Pathway-specific Cell Based Screening System to Detect Bacterial Cell Wall Inhibitors.
-
- SUN DONGYU
- Biogen, Inc.
-
- COHEN SETH
- Millennium Pharmaceuticals Inc.
-
- MANI NAGRAJ
- Vertex Inc.
-
- MURPHY CHRIS
- Essential Therapeutics
-
- ROTHSTEIN DAVID M.
- Demegen, Inc.
この論文をさがす
抄録
A pathway-specific cell-based screen is described to detect compounds that inhibit the biosynthesis of the cell wall of bacteria. The basis for detection is the discovery that the β-lactamase gene from Citrobacter freundii, cloned into Escherichia coli, is induced when cells are exposed to known cell wall inhibitors, and not just β-lactam-based antibiotics. In a wild type host, cell wall inhibitors such as moenomycin, vancomycin, and ramoplanin, which are excluded by the outer membrane, only induce at high concentrations. However, these compounds, as well as fosfomycin, cycloserine, and cefoxitin, induce at concentrations at or below the MIC of a host carrying the envA-mutation, which causes a defect in the outer membrane. As additional proof that induction of β-lactamase is the direct result of cell wall inhibition, a host strain carrying a temperature-sensitive mutation in the murG gene, whose product converts the cell wall intermediate Lipid I, to Lipid II, also induced β-lactamase at the restrictive temperature. A protocol is described for screening samples in high-throughput mode.
収録刊行物
-
- The Journal of Antibiotics
-
The Journal of Antibiotics 55 (3), 279-287, 2002
公益財団法人 日本感染症医薬品協会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204151063936
-
- NII論文ID
- 130003503961
- 10008472267
-
- NII書誌ID
- AA0069330X
-
- COI
- 1:CAS:528:DC%2BD38Xis1aisbo%3D
-
- ISSN
- 18811469
- 00218820
-
- PubMed
- 12014443
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可